Literature DB >> 2411379

Hepatoblastoma producing both alpha-fetoprotein and human chorionic gonadotropin. Clinicopathologic analysis of four cases and a review of the literature.

A Nakagawara, K Ikeda, M Tsuneyoshi, Y Daimaru, M Enjoji, I Watanabe, M Iwafuchi, T Sawada.   

Abstract

A clinicopathologic study was done of four cases of hepatoblastoma with precocious puberty, together with an analysis of 21 such cases reported in the literature. All four patients were males, the age ranging from 11 to 35 months. Three of the four patients died within 12 months after operation, but the fourth is living. Histologically, all patients had a hepatoblastoma with the coexistence of both fetal and embryonal type cells, although predominantly fetal in two and predominantly embryonal in the other two. Tumor giant cells were rarely encountered in all these cases. Both alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) in the serum or urine increased in our four cases and in five other cases reported in the literature. Though the serum AFP level paralleled the severity of clinical symptoms, the serum or urine hCG did not necessarily correspond to the clinical course. It is likely that these poorly prognostic virilizing hepatoblastomas secrete two different tumor markers, AFP and hCG, from different cells, and that these functioning tumor cells may not always exist concurrently in the recurrent or metastatic tumor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411379     DOI: 10.1002/1097-0142(19851001)56:7<1636::aid-cncr2820560729>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Lentivirally engineered dendritic cells activate AFP-specific T cells which inhibit hepatocellular carcinoma growth in vitro and in vivo.

Authors:  Yang Liu; Lisa H Butterfield; Xiaohui Fu; Zhenshun Song; Xiaoping Zhang; Chongde Lu; Guanghui Ding; Mengchao Wu
Journal:  Int J Oncol       Date:  2011-04-13       Impact factor: 5.650

2.  Treatment of unresectable hepatoblastoma with cisplatin, vincristine and 5-fluorouracil.

Authors:  T Herlin; K Norup; K Storm
Journal:  Eur J Pediatr       Date:  1988-06       Impact factor: 3.183

3.  Identification of an HLA-A*24:02-restricted α-fetoprotein signal peptide-derived antigen and its specific T-cell receptor for T-cell immunotherapy.

Authors:  Zhenjuan Li; Haiping Gong; Qiuping Liu; Wanli Wu; Jianting Cheng; Yingyi Mei; Yaolong Chen; Hongjun Zheng; Xiaohong Yu; Shi Zhong; Yi Li
Journal:  Immunology       Date:  2020-01-10       Impact factor: 7.397

4.  Neoplastic causes of abnormal puberty.

Authors:  Susanne Wendt; John Shelso; Karen Wright; Wayne Furman
Journal:  Pediatr Blood Cancer       Date:  2013-10-24       Impact factor: 3.167

5.  AFP-specific CD4+ helper T-cell responses in healthy donors and HCC patients.

Authors:  Viktoria N Evdokimova; Yang Liu; Douglas M Potter; Lisa H Butterfield
Journal:  J Immunother       Date:  2007 May-Jun       Impact factor: 4.456

Review 6.  Paraneoplastic manifestations in children.

Authors:  J H de Graaf; R Y Tamminga; W A Kamps
Journal:  Eur J Pediatr       Date:  1994-11       Impact factor: 3.183

7.  Precocious puberty in an infant with hepatoblastoma: a case report.

Authors:  Usama Al-Jumaily; Ibrahim Sammour; Fadi Al-Muhaisen; Fatenah Ajlouni; Iyad Sultan
Journal:  J Med Case Rep       Date:  2011-08-30

8.  Histological and immunohistochemical study of hepatoblastoma: correlation with tumour behaviour and survival.

Authors:  Kala Gnanasekaran Kiruthiga; Banumathi Ramakrishna; Soumitra Saha; Sudipta Sen
Journal:  J Gastrointest Oncol       Date:  2018-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.